Sitemap
November 28, 2012 Articles
Filter by Available Specialty
- AF may raise risk for sudden cardiac death
- Aldosterone antagonists at discharge failed to improve mortality, CV readmission
- Bedaquiline recommended for accelerated approval for MDR-TB
- BLOG: Inappropriate payments to skilled nursing facilities cost Medicare more than $1 billion
- CDC: Youth account for one-quarter of new HIV infections
- CDC: Youth account for one-quarter of new HIV infections
- Childhood trauma may play larger role in combat soldiers’ PTSD
- Consider patients’ religious faith in the selection of knee arthroscopy products
- DePuy launches access system for posterior-lateral fusion
- Eating fish at a certain age may protect against asthma
- Eliminating Medicare payments for consultations led to net increase in spending
- FDA accepts application for tivozanib in patients with renal cell carcinoma
- Genetic modifications in immune system may play a role in AMD, researchers say
- Half-fluence PDT improves acute symptomatic central serous chorioretinopathy
- Healio Minute Wednesday, Nov. 28, 2012 Edition: Fall fallibility, fructose factors, Medicare misgivings
- HIV treatment reduced risk for malaria recurrence in children
- Increasing substance abuse linked to rising incidence of stroke in young adults
- Influenza revaccination in HCWs prevented nosocomial transfer
- Isovue syringes recalled
- Mechlorethamine gel effectively treated patients with mycosis fungoides
- NAFLD Fibrosis Score inaccurate in patients with elevated BMI
- Phaco with torsional or longitudinal ultrasound may result in high endothelial cell loss
- Researchers predict substantial increase in youth diabetes by 2050
- Simple risk score predicted stent thrombosis
- Statins reduced heart failure risk during anthracycline chemotherapy
- Statins reduced heart failure risk during anthracycline chemotherapy
- Study finds higher readmission rates after spine surgery are unrelated to complication rate
- Study finds more complications for patients with rheumatoid arthritis after TJA
- Symposium addresses difficult-to-treat HCV cases, drug-drug interactions
- Symposium addresses difficult-to-treat HCV cases, drug-drug interactions
- Valeant reports $7.6 million in net income for third quarter